CHEMOS
5A2-SC8

5A2-SC8

Nom chimique

2-[3-[2-[2-[2-[2-[bis[3-[2-(2-methyl-3-octylsulfanylpropanoyl)oxyethoxy]-3-oxopropyl]amino]ethylamino]ethyl-[3-[2-(2-methyl-3-octylsulfanylpropanoyl)oxyethoxy]-3-oxopropyl]amino]ethylamino]ethyl-[3-[2-(2-methyl-3-octylsulfanylpropanoyl)oxyethoxy]-3-oxopropyl]amino]propanoyloxy]ethyl 2-methyl-3-octylsulfanylpropanoate

5A2-SC8•LNP
Structure: 5A2-SC8 structure, CAS 1857341-90-2, MW 1841.72
N° produit
CH51066
CAS
1857341-90-2
FM
C93H173N5O20S5
PM
1841.72
Spécification
Catalog No.CH51066
CAS No.1857341-90-2
Molecular FormulaC93H173N5O20S5
Molecular Weight1841.72

CHEMOS Support for This Category

CHEMOS supports custom synthesis and process development for LNP lipid components, with work planned according to target structure, requested scale, and analytical requirements. Ionizable lipid route development : route scouting, impurity review, stereochemistry control, and purification planning. Helper lipid and PEG-lipid preparation : support for phospholipids, sterol-related components, PEG-lipids, and related analogs. Analytical support : HPLC, NMR, MS, Karl Fischer water content, elemental analysis, and residual-solvent testing can be discussed by project. Scale-up support : transfer from laboratory preparation to larger pilot or production batches after route and quality review. Project documentation : batch-specific COA and technical information are provided according to the confirmed specification.

Vue d’ensemble

5A2-SC8 (CAS 1857341-90-2, MF C93H173N5O20S5, MW 1841.72) belongs to the ionizable lipid class used in LNP delivery system research for mRNA, siRNA and gene-editing cargos. Programs working with this compound usually examine the head-group / tail combination, related-substance profile, and stereochemistry. Bench-scale to larger-scale production is supported through CHEMOS organic chemistry workflows and dedicated process-development resources.

Applications

  • 5A2-SC8 (1857341-90-2) supply and analog preparation for research programs
  • Ionizable lipid library and head-group / tail analog screening
  • Custom analog synthesis with controlled head-group and tail variants
  • Analytical method development for ionizable lipid related substances

Besoin d’une synthèse à façon ?

Notre équipe CDMO accompagne la synthèse à façon, de l’évaluation de voie au développement de procédé et au scale-up.

Voir les services CDMO